SCHEMBL21089491

SCHEMBL21089491

N#Cc1ccc(-c2ccc(-c3cc(-c4cccc5ccccc45)c4nc(-c5ccccc5N)sc4c3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.40
ALOX15 P16050 2/20 0.40
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
LIMK1 P53667 2/20 0.38
APP P05067 1/20 0.37
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21089496 0.88 ALOX15 (0.38) PIM1ALOX15HRH4LIMK1PARP1
SCHEMBL21089456 0.87 ALDH1A1 (0.42) KDM4EMEN1NPC1ALDH1A1GAA
SCHEMBL21089463 0.86 ALDH1A1 (0.41) PIM1ALOX15KDM4EMEN1NPC1
SCHEMBL21089682 0.86 ALDH1A1 (0.43) ALOX15KDM4EMEN1NPC1ALDH1A1
SCHEMBL21089406 0.86 ALOX5 (0.36) PIM1KDM4EMEN1NPC1ALDH1A1
SCHEMBL21089673 0.85 ALDH1A1 (0.47) PIM1ALOX15KDM4EMEN1NPC1
SCHEMBL21089187 0.81 KDM4E (0.50) KDM4EMEN1NPC1ALDH1A1GAA
SCHEMBL21089206 0.80 ALDH1A1 (0.46) ALOX15KDM4EMEN1NPC1ALDH1A1
SCHEMBL21089501 0.79 ALDH1A1 (0.45) ALOX15KDM4EMEN1NPC1ALDH1A1
SCHEMBL21089385 0.77 ALDH1A1 (0.56) PIM1ALOX15KDM4EMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-31 US disclosed
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LAPTO CO., LTD. (KR) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device CHRM1, L1CAM, CHRM4 PIM1 1735/4885ALOX15 3628/4885KDM4E 812/4885
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, L1CAM, CHRM4 PIM1 1735/4885ALOX15 3628/4885KDM4E 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.